What Factors Will Drive Johnson & Johnson’s Q3 Earnings?

Johnson & Johnson will report its Q3 2017 earnings on October 17, and we expect the company to post solid numbers, owing to three primary factors – a ramp up in key oncology drug sales, the Actelion acquisition, and forex gains.October 13, 2017 at 01:40PM

via Forbes Real Time http://ift.tt/2z5D1tu